ADC Therapeutics. Confronting cancer with the full potential of our science.
ADC Therapeutics is a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation, targeted antibody drug conjugates (ADCs). ADC Therapeutics is advancing its proprietary PBD-based ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.
E-mail - Joe.email@example.com
E-mail - Steve.Alvermann@adctherapeutics.com